TEHNOFARM S.R.L. has held a pharmaceutical, biotechnology, and information-technology mandate in the Republic of Moldova since October 1992. The company develops origin-validated raw materials for industrial partners, operates curated consumer brands across European markets, and is extending its mandate into constitutional medical software for environments where conventional clinical infrastructure does not reach.
Era of the essential. Nothing that need not be there.
Six verticals. One mandate. Each vertical addresses a distinct audience: industrial buyers seeking origin-validated raw material; consumers of curated natural pharmacy; users of premium wellness and cosmetic formulations; institutional partners in applied longevity research; operators of environments where medical autonomy is required.
| Vertical | What it is | Audience |
|---|---|---|
| B2B Origin Programmes | Six pharmaceutical-grade cultivation programmes under *-PHARMA® mark | Pharmaceutical extractors, nutraceutical manufacturers, premium culinary processors |
| DMT DIVINEMINDTHERAPY® | B2B raw-materials and private-label platform — in development | Institutional distributors, private-label customers |
| NATUR-FARMA® | Curated consumer natural pharmacy, 21 national domains | European consumers, B2C |
| VESSENSE® | Cosmetics, fragrance, and SPA — premium positioning | European consumers, premium B2C |
| ERINIUM® | Applied longevity research — dual-line: SPACE (peak performance) + TERRA (daily continuity) | B2B medical and performance institutes + premium DTC |
| T.E.H.N.O.F.A.R.M. OS | Constitutional medical software for environments where physicians cannot reach in time | Space programmes, polar / maritime / humanitarian operators, rural primary care |
Each programme is an active R&D framework with documented analytical profiles, regulated supply chain, and field execution by NORD NUC S.R.L. under Moldovan phytosanitary registration.
Pharmaceutical-grade Allium sativum.
Four cultivar lines under field stabilisation: Strămoșesc (Bessarabian heritage), Violet Spring (Moldovan-adapted Spanish), Krasnyi Imperator Tibeta (Tibetan premium), Lyubasha (Ukrainian industrial). Allicin profiles, organosulfur fractions, full phytochemical dossiers under NDA.
Pharmaceutical-grade Ginkgo biloba leaf.
European in-region cultivation for the EGb 761-type extract profile (24% flavone glycosides, 6% terpene lactones). 0.300 ha active plantation in Corbu, Donduşeni raion, under ANSA phytosanitary registration.
Crocus sativus — Moldovan genetic line.
Apocarotenoid pigments (crocins, picrocrocin, safranal) for neurological and mood-related research. Standardisation in progress under NORD NUC operational management. Public-facing material on saffron.md.
Crocus sativus — Italian genetic line.
Parallel Italian-origin counterpart to SAFFRON-PHARMA®. Same species, distinct origin claim, distinct supply chain. Operates as one R&D framework with two genetic-and-geographic origin claims.
Juglans nigra leaf and bark.
Juglone (naphthoquinone), tannins, and flavonoid fractions with documented antimicrobial and antioxidant research interest. 1.050 ha Juglans nigra plantation in Corbu, alongside 0.840 ha Juglans regia Chandler for the food-grade walnut programme.
Frost-hardy Poncirus trifoliata.
Five pharmaceutical research directions across flavonoids (poncirin, naringin), limonoids (limonin, auraptene), and coumarins (imperatorin, phellopterin). Moldovan winter conditions yield stress-validated phytochemical profile.
B2B platform brand for institutional distributors and private-label customers across the natural-products, pharmaceutical, and nutraceutical channels. Trademark filed at AGEPI (Nr. 057329). Operational scope and engagement protocols are being finalised; public communication is intentionally limited until the platform is commercially active.
Not a catalogue. A selection.
NATUR-FARMA® is a curated consumer natural pharmacy. It does not aim to be the largest store of natural products in Europe — it aims to be the one whose shelves a careful pharmacist would assemble. Each product is selected for evidence of effect, quality of source, and integrity of supplier. Sold across twenty-one national domains under the same editorial standard.
The essence of vitality.
VESSENSE® occupies the premium cosmetic, fragrance, and SPA position in the portfolio. Designed as a quiet European luxury brand — restrained, mineral, contemplative. Reaches consumers through vessense.com (.eu, .fr, .it).
Era of the essential.
Nothing that need not be there.
ERINIUM® is the applied longevity research line under TEHNOFARM® pharmaceutical mandate. The brand operates as a master mark with two complementary product lines, each addressing a distinct life context.
Discipline for the seventy-second hour, when discipline must replace stamina.
Designed for the peak-performance window: high-stakes operating periods, intensive cognitive cycles, deep-mission preparation contexts. References 1960s–70s cosmonaut training discipline — a specific historical heritage of extreme-environment human performance.
The protocol is not for tomorrow. It is for the year, and the year after.
The daily counterpart — a continuous monthly cycle pack designed for nervous system equilibrium, preventive resilience, and the long rhythm of years. Positioned as a Monaco-anchored luxury concierge product with subscription economics.
Medical mission control for the moments medicine cannot reach.
Modern medicine assumes a physician will arrive in time. T.E.H.N.O.F.A.R.M. OS is an operating system for clinical behaviour in environments where that assumption does not hold — long-duration space missions, polar stations, deep-water vessels, humanitarian field operations, and rural primary-care contexts where the nearest qualified clinician is a difficult distance away.
The product operates within a written constitutional document and a public-facing operator oath — both designed to satisfy medical, legal, insurance, and certification review. The system serves the physician where the physician is reachable; the system serves life where the physician is not; the system returns every autonomous decision to physician review when contact resumes.
Where there is a physician, the system serves the physician.
Where there is no physician, the system serves life.
Where contact returns, the system returns the decision for review.
Not in place of Hippocrates. After Hippocrates.
For the distance he did not know.
Status. In active development. Patent foundation filed at AGEPI (P1 № 7671, P2 № 7672, P3 in completion before 1 June 2026). Engagement by invitation only.
TEHNOFARM operates as the pharmaceutical R&D and intellectual-property layer of the TF Group. Field execution, infrastructure, and applied software each have their own operational vehicle. The arrangement separates regulatory mandate from execution capacity while keeping both inside the same group structure.
The TF Group operates under documented institutional governance: separated legal vehicles for distinct operational functions; explicit founder accountability through TF HOLDING's sole administration; documented intellectual-property registry at AGEPI; phytosanitary registration with ANSA for field operations; and regulatory positioning aligned with the European Union AI Act framework for the applied software vertical.
No product is claimed compliant, certified, or certification-ready unless evidence exists and the wording has been reviewed. Status language reflects actual state: in development, trademark filed, manufacturing spec locked, cultivation phase, target Q3 2026.
Five registered trademarks at AGEPI. A coordinated patent family covering governance, evidence, and reasoning components used across the TF Group's regulated verticals. International extension path opens via Moldova's accession to the European Patent Convention on 1 June 2026.
Engagement is structured by partner type. Each track has a specific entry point and a defined expectation. Initial inquiries arrive via email; meaningful conversation continues under appropriate confidentiality framework.
For pharmaceutical extractors, nutraceutical manufacturers, premium culinary buyers. Initial conversation under NDA. Specimens and analytical dossiers provided on qualified inquiry.
For space programmes, isolated-environment operators, humanitarian medicine, rural primary care, and institutional research collaborators. Invitation-only window during the pre-filing period.
For regulatory bodies, due-diligence reviewers, qualified institutional inquirers. Banking and compliance details available on written request.
TEHNOFARM S.R.L. · IDNO 1005600002358 · MD-5101 Donduşeni · Republic of Moldova
contact@tehnofarm.md · +373 60 008 884 · +39 352 000 8884